In particular, the finding that S1PR3 mRNA correlated negatively with PTSD symptom severity may provide the groundwork for the development of treatment strategies targeting sphingolipid receptors for stress-related psychiatric disorders including PTSD, anxiety, and depressive disorders. This evidence concerns the gene S1PR3 and depressive disorder.